Molecular aspects of microcystin-induced hepatotoxicity and hepatocarcinogenesis

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 28, Issue 1, 2010, Pages 39-59

  Svircev Z ^a   Baltic V ^b   Gantar, M ^c   Jukovic M ^d   Stojanovic D ^a   Baltic M ^d  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b ONCOLOGY INSTITUTE OF VOJVODINA   (Serbia)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Apoptosis; Cyanotoxins; DNA damage; Hepatocarcinogenesis; Hepatotoxicity; Microcystin LR

Indexed keywords

APOPTOSIS; CYANOTOXINS; DNA DAMAGES; HEPATOCARCINOGENESIS; HEPATOTOXICITY; MICROCYSTIN-LR;

CELL DEATH; DNA; ELECTRIC REACTORS; GENES; OXYGEN; POTABLE WATER; RESERVOIRS (WATER); TOXIC MATERIALS; TUMORS; WATER SUPPLY;

SEMICONDUCTOR COUNTERS;

AFLATOXIN B1; ANTIDIABETIC AGENT; DRINKING WATER; FEXOFENADINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MICROCYSTIN; MYCOTOXIN; REACTIVE OXYGEN METABOLITE;

ALCOHOL CONSUMPTION; APOPTOSIS; CANCER INCIDENCE; CANCER RISK; CELL PROLIFERATION; CELL STRUCTURE; CHEMICAL STRUCTURE; CHINA; CYANOBACTERIUM; DIABETES MELLITUS; DNA DAMAGE; DRUG BLOOD LEVEL; ENVIRONMENTAL EXPOSURE; FLUID INTAKE; GENOTOXICITY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER NECROSIS; LIVER TOXICITY; LONG TERM EXPOSURE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DNA INTERACTION; REVIEW; SERBIA; TUMOR PROMOTION; WATER SUPPLY;

HUMANS; LIVER; LIVER NEOPLASMS; MICROCYSTINS; RISK FACTORS;

CYANOBACTERIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 77951248206     PISSN: 10590501     EISSN: 15324095     Source Type: Journal    
DOI: 10.1080/10590500903585382     Document Type: Review

References (111)

1. Chorus I, Bartram J. Toxic cyanobacteria in water. A guide to their public health consequences, monitoring and management 1999; London: WHO.
2. Yoshida T, Takeda M, Tsutsumi T, Nagata S, Yoshida F, Maita K, Harada T, Ueno Y. Tumor necrosis factor-α expression and kupffer cell activation in hepatotoxicity caused by microcystin-LR in mice. J Toxicol Pathol 2001; 14(4):259. (Pubitemid 33810950)
3. Yu SJ. Primary prevention of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 1995; 10:674-682.
4. Ueno Y, Nagatai S, Tsutsumi T, Hasegawa A, Watanabe M, Park H, Chen G, Chen G, Yu S. Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis. 1996; 17(6):1317-1321. (Pubitemid 26196344)
5. Svirčev Z, Krstíc S, Miladinov-Mikov M, Baltíc V, Vidovíc M. Freshwater cyanobacterial blooms and primary liver cancer epidemiological studies in Serbia. J. Environ. Science Health, Part C 2009; 27(1):36-55.
6. Yu S, Zhao N, Zi X. The relationship between cyanotoxin (microcystin, MC) in pond-ditch water and primary liver cancer in China. Zhonghua Zhong Liu Za Zhi 2001; 23(2):96-99.
7. Sekijima M, Tsutsumi T, Yoshida T, Harada T, Tashiro F, Chen G, Yu SZ, Ueno Y. Enhancement of glutathione S-transferase placental-form positive liver cell foci development by microcystin-LR in aflatoxin B1-initiated rats. Carcinogenesis 1999; 20(1):161-165. (Pubitemid 29033859)
8. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF. International trends and patterns of primary liver cancer. Intl J Cancer 2001; 94:290-296. (Pubitemid 32911426)
9. Hu Z, Chen H, Li Y, Gao L, Sun C. The expression of bcl-2 and bax genes during microcystin induced liver tumorigenesis. Zhonghua Yu Fang Yi Xue Za Zhi 2002; 36(4):239-242.
10. Weng D, Lu Y, Wei Y, Liu Y, Shen P. The role of ROS in microcystin-LR-induced hepatocyte apoptosis and liver injury in mice. Toxicology 2007; 232(1-2):15-23. (Pubitemid 46283168)
11. Humpage AR, Hardy SJ, Moore EJ, Froscio SM, Falconer IR. Microcystins (cyanobacterial toxins) in drinking water enhance the growth of aberrant crypt foci in the mouse colon. J. Toxicol. Environ. Health, Part A 2000; 61(3):155-165.
12. Žegura B, Volčič M, Lah TT, Filipič M. Different sensitivities of human colon adenocarcinoma (CaCo-2), astrocytoma (IPDDC-A2) and lymphoblastoid (NCNC) cell lines to microcystin-LR induced reactive oxygen species and DNA damage. Toxicon 2008; 52(3):518-525.
13. Milutinovíc A, Zorc-Pleskovíc R, Petrovíc D, Zorc M, Šuput D. Microcystin-LR Induces Alterations in Heart Muscle. Folia Biologica (Praha) 2006; 52:116-118. (Pubitemid 44613136)
14. Li H, Xie P, Li G, Hao L, Xiong Q. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins. Toxicon 2009; 53(1):169-175.
15. Nishiwaki-Matsushima R, Ohta T, Nishiwaki S, Suganuma M, Kohyama K, Ishikawa T, Carmichael WW, Fujiki H. Liver tumour promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J. Cancer Res. Clin. Oncol 1992; 118:420-424.
16. Carmichael WW. A review: cyanobacteria secondary metabolites-the cyanotoxins. J. Applied Bacteriology 1992; 72:445-459.
17. IARC. Ingested nitrate and nitrite, and cyanobacterial peptide toxins. International Agency for Research on Cancer IARC monographs on the evaluation of carcinogenic risks to humans. Vol.94. Lyon: IARC; 2006.
18. Ito E, Kondo F, Terao K, Harada K-I. Neoplastic nodular formation in mouse liver induced by repeated intraperitoneal injections of microcystin-LR. Toxicon 1997; 35:1453-1457. (Pubitemid 27478851)
19. Ding WX, Shen HM, Zhu HG, Lee BL, Ong CN. Genotoxicity of microcystic cyanobacteria extract of a water source in China. Mutation Research 1999; 442(2):69-77.
20. Abdel-Hamid N. Update to risk factors for hepatocellular carcinoma. International J. Medicine Medical Sci 2009; 1(3):38-43.
21. Žegura B, Zajc I, Lah TT, Filipič M. Patterns of microcystin-LR induced alteration of the expression of genes involved in response to DNA damage and apoptosis. Toxicon 2008; 51:615-623.
22. Dietrich D, Hoeger S. Guidance values for microcystins in water and cyanobacterial supplement products (blue-green algal supplements): A reasonable or misguided approach? Toxicol. Applied Pharmacol 2005; 203(3):273-289. (Pubitemid 40311874)
23. WHO. Cyanobacterial toxins: Microcystin-LR. In: Guidelines for drinking-water quality, Addendum to Volume2. Geneva: World Health Organization; 1998.
24. Rudolph-Böhner S, Mierke DF, Moroder L. Molecular structure of cyanobacterial tumour-promoting microcystins. FEBS Letters 1994; 349:319-323. (Pubitemid 24264766)
25. Annila A, Lehtimäki J, Manila K, Eriksson JE, Sivonen K, Rantala TT, Drakenberg T. Solution structure of nodularin an inhibitor of serine/threonine specific protein phosphatases. J. Biol. Chem 1996; 271(28):16695-16702. (Pubitemid 26239032)
26. Barford D, Keller J. Co-crystallization of the catalytic subunit of the serine/ threonine specific protein phosphatase 1 from human in complex with microcystin- LR. J. Molec. Biol 1994; 235:763-766. (Pubitemid 24063593)
27. Goldberg J, Huang HB, Kwon YG, Greengard P, Nairn AC, Kuriyan J. Threedimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1. Nature 1995; 376:745-753.
28. Carmichael WW, Beasley VR, Bunner DL, Eloff JN, Falconer I, Gorham P, Harada KI, Krishnamurthy T, Yu MJ, Moore RE, Rinehart K, Runnegar M, Skulberg OM, Watanabe M. Naming of cyclic heptapeptide toxins of cyanobacteria (blue-green algae). Toxicon 1988; 26:971-973. (Pubitemid 19012021)
29. Fewer DP, Rouhiainen L, Jokela J, Wahlsten M, Laakso K, Wang H, Sivonen K. Recurrent adenylation domain replacement in the microcystin synthetase gene cluster. BMC Evolutionary Biology 2007; 7:183.
30. Nicholson BC, Burch MD. Evaluation of analytical methods for detection quantification of cyanotoxins in relation to Australian drinking water guidelines. Cooperative Research Centre for Water Quality and Treatment, National Health and Medical Research Council of Australia, Australia, 2001. Available at http://www.nhmrc.gov.au/publications/synopses/ files/eh22.pdf (Oct 10, 2009)
31. Li X, Lin Y, Seng L, Lin J. Responses of antioxidant systems in the hepatocytes of common carp (Cyprinus carpio L.) to the toxicity of MC-LR. Toxicon 2003; 42(1):85-89. (Pubitemid 37297564)
32. Brooks WP, Codd GA. Distribution of Microcystis aeruginosa peptide toxin and interactions with hepatic microsomes in mice. Pharmacol. Toxicol 1987; 60(3):187-191.
33. Robinson NA, Matson CF, Pace JG. Association of microcystin-LR and its biotransformation product with a hepatic-cytosolic protein. J. Biochem. Toxicol 1991; 6:171-180.
34. Kondo F, Matsumoto H, Jamada S, Ishikawa N, Ito E, Nagata S, Ueno Y, Suzuki M, Horada K. Detection and identification of metabolits of microcystins formed in vivo in mouse and rat livers. Chem. Res. Toxicol 1996; 9:1355-1359. (Pubitemid 26403843)
35. Gehringer MM, Shepard EG, Downing TG, Wiegand C, Nielan BA. An Investigation into the detoxication of microcystin LR by the glutathione pathway in Balb/C mice. Intl. J. Biochem. Cell Biol 2004; 35(5):931-934. (Pubitemid 38299408)
36. Robinson NA, Pace JG, Matson CF,Miura GA, LawrenceWB. Tissue distribution, excretion and hepatic biotransformation of microcystin-LR in mice. J. Pharmacol. Exp. Therap 1991; 256(1):176-182.
37. Ito E, Takai A, Kondo F, Masui H, Imanishi S, Harada KI. Comparison of protein phosphatase inhibitory activity and apparent toxicity of microcystins and related compounds. Toxicon 2002; 40(7):1017-1025. (Pubitemid 34663695)
38. Hamm-Alvarez SF, Sheetz MP. Microtubule-dependent vesicle transport: Modulation of channel and transporter activity in liver and kidney. Physiolog. Reviews 1998; 78:1109-1129.
39. Corwin EJ. Handbook of pathophysiology: Foundations of health & disease. Philadelphia: Lippincott Williams & Wilkins; 2006.
40. Fu WY, Xu LH, Yu YN. Proteomic analyses of cellular response to microcystin in human amnion FL cells. J. Proteomic Res 2005; 4:2207-2215. (Pubitemid 41814289)
41. Hiraga A, Tamura S. Protein phosphatase 2A is associated in an inactive state with microtubules through 2A-1- specific interaction with tubuline. Biochem J 2000; 346(2):433-439. (Pubitemid 30148130)
42. Kumar V, Abbas AK, Fausto N. Robins and Cortan pathologic basis of disease. Philadelphia: Elsevier Saunders; 2005.
43. Runnegar MT, Wei X, Hamm-Alvarez SF. Increased protein phosphorylation of cytoplasmic dynein results in impaired motor function. Biochem J 1999; 15(342):1-6. (Pubitemid 29410841)
44. Falconer IR, Yeung SK. Cytoskeletal changes in hepatocytes induced by Microcystis toxins and their relation to hyperphosphorylation of cell proteins. Chem.-Biol. Interactions 1992; 81:181-196.
45. Clark SP, Davis MA, Ryan TP, Searfoss GH, Hooser SB. Hepatic Gene Expression Changes in Mice Associated with Prolonged Sublethal Microcystin Exposure. Toxicologic Patholology 2007; 35(4):594-605.
46. Ghosh S, Khan SA, Wickstrom M, Beasley V. Effects of microcystin-LR on actin and the actin-associated proteins alpha- actinin and talin in hepatocytes. Natural Toxins 1995; 3(6):405-414.
47. McDermott CM, Nho CW, Howard W, Holton B. The cyanobacterial toxin, microcystin-LR, can induce apoptosis in a variety of cell types. Toxicon 1998; 36:1981-1996. (Pubitemid 28532776)
48. Chen T,Wang Q, Cui J, YangW, Shi Q, Hua Z, Ji J, Shen P. Induction of apoptosis in mouse liver by microcystin-LR: A combined transcriptomic, proteomic, and simulation strategy. Molec Cell Proteomics 2005; 4:958-974. (Pubitemid 41309153)
49. Mereish KA, Bunner DL, Ragland DR, Creasia DA. Protection against microcystin-LR-induced hepatotoxicity by Silymarin: biochemistry, histopathology, and lethality. Pharmaceut Res 1991; 8(2):273-277.
50. Lu H, Choudhuri S, Ogura K, Csanaky IL, Lei X, Cheng X, Song PZ, Klaassen CD. Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR. Toxicol Sci 2008; 103(1):35-45. (Pubitemid 351524475)
51. Moreno I, Pichardo S, Jos A, Ǵomez-Amores L, Mate A, Vazquez CM, Caméan AM. Antioxidant enzyme activity and lipid peroxidation in liver and kidney of rats exposed to microcystin-LR administered intraperitoneally. Toxicon 2005; 45(4):395-402. (Pubitemid 40269929)
52. Billam M. Development and validation of microcystin biomarkers for exposure studies (dissertation). Texas: Texas Tech University; 2006.
53. Hooser SB. Fulminant hepatocyte apoptosis in vivo following microcystin-LR administration to rats. Toxicologic Pathology 2000; 28(5):726-733.
54. Billam M, Mukhi S, Tanga L, Gaoa W, Wang JS. Toxic response indicators of microcystin-LR in F344 rats following a single-dose treatment. Toxicon 2008; 51:1068-1080.
55. Ding WX, Shen HM, Ong CN. Microcystic cyanobacteria extract induces cytoskeletal disruption and intracellular glutathione alteration in hepatocytes. Environ. Health Persp 2000; 108(7):605-609.
56. Sedmak B, Šuput D. Co-operative effects in tumorigenicity. The microcystin example. Radiology & Oncology 2002; 36(2):162-164. (Pubitemid 34799946)
57. Leong TY, Leong AS. Epidemiology and carcinogenesis of hepatocellular carcinoma. HPB (Oxford) 2005; 7(1):5-15.
58. Fisher WJ, Altheimer S, Cattori V, Meier PJ, Dietrich DR, Hagenbuch B. Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin. Toxicol. Applied Pharmacol 2005; 203(3):257-263. (Pubitemid 40311872)
59. Chen T, Cui J , Liang Y, Xin X, Young DO, Chen C, Shen P. Identification of human liver mitochondrial aldehyde dehydrogenase as a potential target for microcystin- LR. Toxicology 2006; 220(1):71-80. (Pubitemid 43197631)
60. Holmes CFB, Craig M, McCready TL, Boland MP, Dawson JF, Chen DZX, Wang K, Klix H, Luu HA, et al. Regulation of signal transduction pathways by peptide toxins. In: RS Hodges and JA Smith (Eds.), Proc 13th Am Pept Symp. Leiden: ESCOM; 1994:577-579.
61. Bagu JR, Sykes B, Craig M, Holmes CFB. A molecular basis for different interactions of marine toxins with protein phosphatase 1. J. Biol. Chem 1997; 272:5087-5097.
62. Mac Kintosh RV, Dalby KN, Campbell DG, Choen PT, Choen P, Mac Kintosh C. The cyanobacterial toxin microcystin binds covalently to cisteine-273 on protein phosphatase-1. FEBS Letters 1995; 371(3):236-240.
63. Favre B, Turowski P, Hemmings BA. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J. Biol. Chem 1997; 272(21):13856-13863. (Pubitemid 27224826)
64. Berndt N. Protein dephosphorylation and the intracellular control of the cell number. Frontiries in Bioscience 1999; 4:D22-42.
65. Garcia A, Cayla X, Guergnon J, Dessauge F, Hospital V, Rebollo MP, Fleischer A, Rebollo A. Serine/threonine protein phosphatases PP-1 and PP-2A are key players in apoptosis. Biochimie 2003; 85(8):721-726. (Pubitemid 37383789)
66. Van Hoof C, Goris J. Phosphatases in apoptosis: to be or not to be, PP-2A is in the heart of the question. Biochim. Biophys. Acta 2003; 1640(2-3):97-104. (Pubitemid 36555695)
67. Honkanen RE, Zwiller J, Moore RE, Daily SL, Khatra BS, Dukelow M, Boynton AL. Characterization ofmicrocystin- LR, a potent inhibitor of type 1 and type 2A protein phosphatases. J. Biol. Chem 1990; 265:19401-19404. (Pubitemid 120013875)
68. Runnegar MTC, Kong SM, Berndt N. Protein phosphatase inhibition and in vivo hepatotoxicity of microcystins. Am. J. Physiol 1993; 265(2 part 1):G224-G230. (Pubitemid 23273625)
69. Wera S, Hemmings BA. Serine/threonine protein phosphatases. Biochem. J 1995; 311(1):17-29
70. Yamano H, Ishii K, Yanagida M. Phosphorylation of dis2 protein phosphatase at the C-terminal cdc2 consensus and its potential role in cell cycle regulation. EMBO J 1994; 13:5310-5318. (Pubitemid 24351809)
71. Cohen P. The structure and regulation of protein phosphatases. Ann. Rev. Biochem 1989; 58:453-508. (Pubitemid 19172978)
72. Li H-H, Cai X, Shouse GP, Piluso LG, Liu X. A specific PP2A regulatory subunit, B56, mediates DNA damage-induced dephosphorylation of p53 at Thr55. EMBO J 2007; 26:402-411. (Pubitemid 46160941)
73. Ho R, Choi L, Lee W, Mayo G, Shwartz UI, Tirona RG. Effect of drug transporter genotipes on pravastatin disposition in Europa-and Africa-American participants. Farmacogenet Genomics 2007; 17: 647-656. (Pubitemid 47057714)
74. ZhangW, He YJ, Han CT, Liu ZQ, Li Q, Fan L. Effect of SICO1B1 genetic polymorphism on the pharmacokinetics of nateglinide. Br. J. Clin. Pharmacol 2006; 62:567-572. (Pubitemid 44571578)
75. Niemi M, Kvisto KT, Hofmann U, Shwab M, Eichelbaumm M, Fromm MF. Fexofenadine farmacokinetics are associated with a polymorphism of the SLOC1B1 gene (encoding OATP1B1). Br. J. Clin. Pharmacol 2005; 59:602-604. (Pubitemid 40632253)
76. 2+ in microcystineinduced mitochondrial permeability transition in rat hepatocytes. Biochem. Biophys. Res. Comm 2001; 285:1155-1161. (Pubitemid 32912901)
77. Dürr R, Caselmann WH. Carcinogenesis of primary liver malignancies. Langenbeck's Arch Surg 2000; 385:154-161. (Pubitemid 30316916)
78. Beasley V. Introduction to the Toxicology of the Liver. In: V Beasley (Ed.), Veterinary Toxicology. International Veterinary Information Service (Available from www.ivis.org); 1999.
79. Zegurǎ B, Sedmak, B, Filipič M. Microcystin-LR induces oxidative DNA damage in human hepatoma cell line HepG2. Toxicon 2003; 41:41-48. (Pubitemid 35449159)
80. Serban G, Kouchi Z, Baki L, Georgakopoulos A, Litterst CM, Shioi J, Robakis NK. Cadherins mediate both the association between PS1 and beta-catenin and the effects of PS1 on beta-catenin stability. J. Biol. Chem 2005; 280(43):36007-36012. (Pubitemid 41633870)
81. Saffroy R, Lemoine A, Debuire B. Mechanisms of hepatocarcinogenesis. Atlas Genet Cytogenet Oncol Haematol. 2006. Available at http:// AtlasGeneticsOncology.org/ Deep/HepatocarcinogenesisID20055.html
82. Bouaicha N, Maatouk I, Plessis MJ, Perin F. Genotoxic potential of Microcystin- LR and nodularin in vitro in primary cultured rat hepatocytes and in vivo in rat liver. Environ. Toxicol 2005; 20(3):341-347. (Pubitemid 40827454)
83. Shen CL, Song W, Pence BC. Interactions of selenium compounds with other antioxidants in DNA damage and apoptosis in human normal keratinocytes. Cancer Epidemiology Biomarkers & Prevention 2001; 10(4):385-390. (Pubitemid 32703224)
84. Rao PVL, Bhattacharya R. The cyanobacterial toxin microcystin-LR induced DNA damage in mouse liver in vivo. Toxicology 1996; 114:29-36. (Pubitemid 26379365)
85. Honma M, Momose M, Tanabe H, Sakamoto H, Yu Y, Little JB, Sofuni T, Hayashi M. Requirement of wild-type p53 protein for maintenance of chromosomal integrity. Molecular Carcinogenesis 2000; 28(4):203-214.
86. Zan L, Sakamoto H, Sakuraba M, Wu DS, Zhang LS, Suzuki T, Hayashi M, Honma M. Genotoxicity of microcystin-LR in human lymphoblastoid TK6 cells. Mutation Research 2004; 557(1):1-6. (Pubitemid 38045576)
87. Suzuki H, Watanabe MF, Wu Y, Sugita T, Kita K, Sato T, Wang XL, Tanzawa H, Sekiya S, Suzuki N. Mutagenicity of microcystin-LR in human RSa cells. Intl. J. Molec. Med 1998; 2:109-112.
88. Alvarca E, Andrade M, Dias E, Sam Bento F, Batoreu MCC, Jordan P, Silva MJ, Pereira P. Morphological and ultrastructural effect of MC-LR from Microcystins aeruginose extracts on a kidney cell line. Toxicon 2009; 30:1-12.
89. Guzman RE, Solter PF. Characterization of subletal MC-LR exposure in mice. Veterinary Pathology 2002; 39(1):17-26.
90. Andreeff M, Goodrich DW, Pardee AB. Cell proliferation, differentiation and apoptosis. In: JF Holland & E Frei (Eds.), Cancer Medicine. 5 ed. London: B.C. Decker Inc, Hamilton; 2000:24-32.
91. Tan XW, Xia H, Xu JH, Cao JG. Induction of apoptosis in human liver Hep2 cell line by 5-acyl-7-gen-difluoromethilenechrysin. World J. Gastroenterology 2009; 15(18):2234-2239.
92. Wen-yu F, Jia-ping C, Xiu-min W, Li-hong X. Altered expression of p53, Bcl- 2 and Bax induced by microcystin-LR in vivo and in vitro. Toxicon 2005; 46(2):171-177.
93. Falconer Y. Cyanobacterial toxins of drinking water supplies. Cylindrospermopsin and microcystin. CRC Press, Boca Raton, Florida, 2005.
94. Humpage AR, Falconer IR. Microcystin-LR and liver tumor promotion: effects on cytokinesis, ploidy, and apoptosis in cultured hepatocytes. Environ. Toxicol 1999; 14:61-75. (Pubitemid 129721405)
95. Cinique B, DiMarizio L, Centi C, DiRocco C, Riccardi C, Graziacifone M. Sphingolipids and the immune system. Pharmacol. Res 2003; 47(5):421-437. (Pubitemid 36379204)
96. Chiang, CW, Harris G, Ellig C, Masters SC, Subramanian R, Shenolikar S. Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin-3- dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood 2001; 97:1289-1297. (Pubitemid 32183751)
97. Wang J, Lv X, Shi J, Hu X. Ceramide induces apoptosis via a peroxisome proliferator activated receptor -γ-dependent pathway. Apoptosis 2006; 11:2043-2045. (Pubitemid 44691586)
98. Falconer IR, Burch MD, Steffensen DA, Choice M, Coverdale OR. Toxicity of the blue-green alga (cyanobacterium) Microcystis aeruginosa in drinking water to growing pigs, as an animal model for human injury and risk assessment. Enviro. Toxicol. Water Quality 1994; 9:131-139. (Pubitemid 24141384)
99. Gehringer MM. Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response. FEBS Letters 2004; 557:1-8.
100. Toivola DM, Eriksson JE. Toxins affecting cell signaling alter cytoskeletal structure. Toxicology In Vitro 1999; 13:521-530.
101. Deng X, Ito T, Carr B, Mumby M, May WS Jr. Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A. J. Biol. Chem 1998; 273(51):34157-34163. (Pubitemid 29008888)
102. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258:607-614. (Pubitemid 24075388)
103. Komatsu M, Furukawa T, Ikeda R, Takumi S, Nong Q, Aoyama K, Akiyama S, Keppler D, Takeuchi T. Involvement of mitogen-activated protein kinase signaling pathways in microcystin-LR-induced apoptosis after its selective uptake mediated by OATP1B1 and OATP1B3. Toxicol. Sci 2007; 97(2):407-416. (Pubitemid 47073856)
104. Wei Y, Weng D, Li F, Zou X, Young DO, Ji J, Shen P. Involvement of JNK regulation in oxidative stress-mediated murine liver in JURY by Microcystine-LR. Apoptosis 2008; 13:1031-1042.
105. Lankoff A, Bialczyk J, Dziga D, Carmichael WW, Gradzka I, Lisowska H, Kuszewski T, Gozdz S, Piorun I,Wojcik A. The repair of gamma-radiation-induced DNA damage is inhibited by microcystin-LR, the PP-1 and PP-2A phosphatase inhibitor. Mutagenesis 2006; 21(1):83-90. (Pubitemid 43288742)
106. Clark SP, Ryan TP, Searfoss GH, Davis MA, Hooser SB. Chronic microcystin exposure induces hepatocyte proliferation with increased expression of mitotic and cyclinassociated genes in P53-deficient mice. Toxicologic Pathology 2008; 36(2):190-203.
107. Fujiki H, Suganuma M. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv. Cancer Res 1993; 61:143-194. (Pubitemid 23266387)
108. Milczarek GJ, Chen W, Gupta A, Martinez JD, Bowden T. Okadaic acid mediates p53 hyperphosphorylation and growth arrest in cells with wild-type p53 but increases aberrant mitoses in cells with non-functional p53. Carcinogenesis 1999; 20(6):1043-1048. (Pubitemid 29263749)
109. Markovics JA. The roles of the Rb and p53 tumor suppressor pathways in an intestinal tumorigenesis model system (dissertation). Pittsburgh, USA: University of Pittsburgh; 1999.
110. Hu Z, Chen H, Pang C, Lin Q. The expression of p53 and p16 in the course of microcystin-LR inducing of liver tumor. The Chinese-German Journal of Clinical Oncology 2008; 7(12):690-693.
111. Maximov GK, Maximov KG. The role of p53 tumor-suppressor protein in apoptosis and cancerogenesis. Biotechnology & Biotechnological Equipment 2008:664-668. (Pubitemid 351920006)